Prompt Reversing the Neurologic and Cardiac Manifestations of Valproate Poisoning by Hemodialysis: A Case Report

سال انتشار: 1401
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 142

فایل این مقاله در 5 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_RCM-9-4_006

تاریخ نمایه سازی: 5 اردیبهشت 1402

چکیده مقاله:

SV (sodium valproate) is an antiepileptic drug that is often prescribed for epilepsy, bipolar disorders, and migraine. We reported an SV intoxicated case that cardiac and neurologic abnormalities were promptly responded to hemodialysis (HD). She ingested a large amount of SV (۱۵۰ pills of SV ۲۰۰mg) for a suicide attempt. She was initially alert but her Glasco coma scale (GCS) decreased to ۶ thought ۱۱ hours. However, valproate (>۱۵۰mg/l) and ammonia serum (۱۶۴µg/dL) levels were not excessively elevated. The serial electrocardiography (ECG) showed QT prolongation and a signs of sodium channel block such as dominant R wave in AVR lead and T-wave inversion in the precordial leads. She had low level of calcium and potassium serum levels. Supportive treatment, charcoal, and L-carnitine, were not effective and HD was started due to the resistant cardiac and neurologic symptoms. After a ۳-hour HD session, decreased GCS, pathological ECG findings, and laboratory abnormalities dramatically disappeared. In conclusion, HD is an effective and rapid response treatment for Valproate-induced loss of consciousness and life-threatening cardiac abnormality.

نویسندگان

Ahmad Nemati

student, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.

Farkhonde Nikkhah

Medical Student, Mazandaran University of Medical Sciences, Mazandaran, Iran

Mohammad Moshiri

Assistant Professor, MD, PhD in Toxicology, Medical toxicology research center, faculty of Medicine. Mashhad University of Medical Sciences, Mashhad, Iran

Hanie Salmani Izadi

student, Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

Leila Etemad

Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran